COVID-19 and seizures: Is there a link?

被引:63
|
作者
Vohora, Divya [1 ]
Jain, Shreshta [1 ]
Tripathi, Manjari [2 ]
Potschka, Heidrun [3 ]
机构
[1] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmacol, New Delhi 110062, India
[2] All India Inst Med Sci, Dept Neurol, New Delhi, India
[3] Ludwig Maximilians Univ Munchen, Inst Pharmacol Toxicol & Pharm, D-110062 Munich, Germany
关键词
CNS; COVID-19; SARS-CoV-2; seizures; RESPIRATORY SYNDROME CORONAVIRUS; RENIN-ANGIOTENSIN SYSTEM; CENTRAL-NERVOUS-SYSTEM; INFECTION; EPILEPSY; IL-6; HIPPOCAMPUS; INHIBITION; PNEUMONIA; RECEPTOR;
D O I
10.1111/epi.16656
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The rapid spread of the SARS-CoV-2 pandemic poses particular challenges to the management of persons with chronic disease. Reports of a possible neuroinvasiveness of SARS-CoV-2 as well as pathophysiological mechanisms and indirect consequences in severe COVID-19 cases raise the question of whether the infection can be associated with an increased risk of seizure recurrence or the development of new onset and acute symptomatic seizures. Although the literature does not provide relevant evidence for seizure worsening in persons with epilepsy during the course of a SARS-CoV-2 infection, there are theoretical risks, for example, seizures triggered by fever. Moreover, a severe disease course and advanced disease stages can, for instance, result in hypoxic encephalopathy, cerebrovascular events, and cytokine storm, which may trigger the development of acute seizures. This is further confirmed by reports of occasional seizures in COVID-19 patients. Although the low number of reports so far suggests that the risk may be relatively low, the reports indicate that an early neurological manifestation with seizures should not be ruled out. In the context of these cases, we discuss possible pathophysiological mechanisms that may trigger ictogenesis in patients with SARS-CoV-2 infection.
引用
收藏
页码:1840 / 1853
页数:14
相关论文
共 50 条
  • [31] Miller Fisher syndrome and COVID-19: is there a link?
    Ray, Amanda
    BMJ CASE REPORTS, 2020, 13 (08)
  • [32] Environmental factors: a “missing link” in COVID-19
    Stefanie Gilles
    Athanasios Damialis
    Claudia Traidl-Hoffmann
    Allergo Journal International, 2021, 30 (3) : 115 - 118
  • [33] Environmental Factors, a "missing link" for COVID-19
    Gilles, Stefanie
    Damialis, Athanasios
    Traidl-Hoffmann, Claudia
    ALLERGO JOURNAL, 2021, 30 (03) : 66 - 68
  • [34] Diabetes and severity of COVID-19: What is the link?
    Pitocco, D.
    Viti, L.
    Tartaglione, L.
    Di Leo, M.
    Rizzo, G. E.
    Manto, A.
    Rizzi, A.
    Caputo, S.
    Pontecorvi, A.
    MEDICAL HYPOTHESES, 2020, 143
  • [35] The link between selenium and COVID-19 recovery
    Malochleb, Margaret
    FOOD TECHNOLOGY, 2020, 74 (06) : 14 - 15
  • [37] Encephalopathy, Epileptiform Activity, and Seizures in Patients with COVID-19
    Klein, Sara
    Abumurad, Sumayyah
    de Lima, Fabiane Santos
    Issa, Naoum P.
    Wu, Shasha
    Rose, Sandra
    Tao, James X.
    ANNALS OF NEUROLOGY, 2021, 90 : S107 - S108
  • [38] Seizures in COVID-19: the relationship between biomarkers and prognosis
    Pınar Bengi Boz
    Kezban Aslan-Kara
    Zeynep Selcan Şanlı
    Mehmet Taylan Peköz
    Dilek Acar
    Hacer Bozdemir
    Acta Neurologica Belgica, 2023, 123 : 1763 - 1772
  • [39] Acute symptomatic epileptic seizures associated with COVID-19
    Mauritz, Matthias
    Trinka, Eugen
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2021, 34 (04): : 390 - 395
  • [40] Rapid development of seizures and PRES in a COVID-19 patient
    de Lima, Fabiane Santos
    Klein, Sara
    El Ammar, Faten
    Wu, Shasha
    Rose, Sandra
    Tao, James X.
    Issa, Naoum P.
    EPILEPSY & BEHAVIOR REPORTS, 2021, 15